Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BIND Therapeutics, a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, has announced a research collaboration with Affilogic, a privately held biotechnology company developing affinity proteins called ...
read more
Friday, November 18, 2016
Medidata a global provider of cloud-based solutions and data analytics for clinical research, has announced the launch of the Medidata eConnect Partner Program. The collaborative initiative will enable the seamless integration of healthcare data—from...
read more
Wednesday, March 13, 2019
CURE has broadened its DEA license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic CBD.
read more
Friday, September 08, 2023
Eminence Biotechnology (Suzhou) Co., Ltd. announced that its state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Argonaut announced the California Department of Public Health, FDB has inspected and approved Argonaut’s new Drug Product Manufacturing facility.
read more
Wednesday, September 25, 2013
Clariant, a world leader in specialty chemicals, represented by its Masterbatches Business Unit with business segments Healthcare Packaging and Masterbatches for medical applications, will exhibit and present at InnoPack 2013, a co-event at CPhI in ...
read more
Wednesday, November 18, 2015
Sandoz, a Novartis company, has announced today the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Neulasta® (pegfilgrastim)* - a...
read more
Monday, November 06, 2017
Applied StemCell has received certifications for two ISO QMS on October 20, 2017, the ISO 9001:2015 and 13485:2016.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Wednesday, December 19, 2012
IGI Laboratories, Inc., a New Jersey based generic topical pharmaceutical company, today announced that Dr. Kenneth Miller has been appointed Senior Vice President of R&D at IGI Laboratories, Inc. effective December 17, 2012.
read more
Thursday, October 29, 2015
SGS Life Science Services has installed and validated instrumentation which uses frequency modulation spectroscopy (FMS) for headspace oxygen analysis of biopharmaceutical container closure systems, as well as imaged capillary isoelectric focusing (...
read more
New industry research explores the greatest barriers to serialization success as companies across the pharmaceutical supply chain prepare for new regulations in the US and Europe.
read more
Tuesday, January 28, 2014
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) West Coast conference January 28-29 in Burlingame.
read more
Wednesday, April 16, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has led a consortium, also comprising Charnwood Technical Consulting, CatScI and Biocatalysts, which has successfully won a Technology Strategy Board grant...
read more
Evotec AG announced it will make a strategic investment as part of Facio Therapies' 2017 funding round together with the Facioscapulohumeral dystrophy community.
read more